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Background. An argument often used to support the view that psychotic experiences (PEs) in general population
samples are a valid phenotype for studying the aetiology of schizophrenia is that risk factors for schizophrenia show
similar patterns of association with PEs. However, PEs often co-occur with depression, and no study has explicitly tested
whether risk factors for schizophrenia are shared between PEs and depression, or are psychopathology speciﬁc, while
jointly modelling both outcomes.
Method. We used data from 7030 subjects from a birth cohort study. Depression and PEs at age 18 years were assessed
using self-report questionnaires and semi-structured interviews. We compared the extent to which risk factors for schizo-
phrenia across sociodemographic, familial, neurodevelopmental, stress–adversity, emotional–behavioural and substance
use domains showed different associations with PEs and depression within bivariate models that allowed for their
correlation.
Results. Most of the exposures examined were associated, to a similar degree, with an increased risk of both outcomes.
However, whereas female sex and family history of depression showed some discrimination as potential risk factors for
depression and PEs, with stronger associations in the former, markers of abnormal neurodevelopment showed stronger
associations with PEs.
Conclusions. The argument that PEs are valid markers for studying the aetiology of schizophrenia, made simply on the
basis that they share risk factors in common, is not well supported. PEs seem to be a weak index of genetic and environ-
mental risk for schizophrenia; however, studies disentangling aetiological pathways to PEs from those impacting upon
co-morbid psychopathology might provide important insights into the aetiology of psychotic disorders.
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Introduction
Psychotic experiences (PEs) such as delusions and
hallucinations can be elicited using semi-structured
interviews in approximately 5% of adolescents and
young adults in the general population (Linscott &
van Os, 2013). Delusions and hallucinations are key
diagnostic features of schizophrenia, and studying
PEs may increase our understanding of how schizo-
phrenia develops if PEs in general population
samples result from aetiological mechanisms under-
lying schizophrenia.
PEs during childhood are associated with an
increased risk of schizophrenia spectrum and other
psychotic disorders during adult life (Hanssen et al.
2005; Welham et al. 2009b; Werbeloff et al. 2012;
Fisher et al. 2013; Zammit et al. 2013b), but the positive
predictive value of such experiences is low (Poulton
et al. 2000; Dhossche et al. 2002; Dominguez et al.
2011; Werbeloff et al. 2012; Zammit et al. 2013b).
Consequently, evidence often used to support the
view that PEs constitute a valid phenotype for study-
ing the aetiology of schizophrenia is that risk factors
for schizophrenia (Malmberg et al. 1998; Mortensen
et al. 1999; Cannon et al. 2002b; McGrath et al. 2004;
Wicks et al. 2005; Moore et al. 2007; Morgan & Fisher,
2007; van Os & Kapur, 2009; Welham et al. 2009a)
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show similar patterns of association with PEs, with
reports that PEs are associated with male sex (van Os
et al. 2009; Kelleher et al. 2012a), family history of schizo-
phrenia (Krabbendam et al. 2004; Polanczyk et al. 2010),
migrant or ethnic minority status (van Os et al. 2009),
urbanicity (Dominguez et al. 2010; Polanczyk et al.
2010), socio-economic disadvantage (van Os et al.
2009; Polanczyk et al. 2010; Zammit et al. 2013b), preg-
nancy and birth complications (Zammit et al. 2009), de-
velopmental impairments (Cannon et al. 2002a), lower
IQ (Cannon et al. 2002a; Horwood et al. 2008), stressful
and traumatic experiences (Arseneault et al. 2011),
peer victimization (Schreier et al. 2009), poorer social
adjustment (Polanczyk et al. 2010) and cannabis use
(Moore et al. 2007).
However, the overlap in the epidemiology of PEs
with that for schizophrenia is not entirely consistent,
with some studies reporting that PEs are observed
more frequently in women (van Os et al. 2000;
Breetvelt et al. 2010; Binbay et al. 2012; Nuevo et al.
2012; Zammit et al. 2013b) or in those living in rural
areas (Wiles et al. 2006; Bartels-Velthuis et al. 2010),
or failing to ﬁnd evidence of increased risk of PEs in
those with a family history of schizophrenia (Zammit
et al. 2008). Even where epidemiological ﬁndings for
schizophrenia and PEs are consistent, it is questionable
to what extent these demonstrate evidence of shared
aetiology, given that most of the factors associated
with increased risk of schizophrenia and PEs are also
associated with other psychiatric outcomes. For exam-
ple, socio-economic adversity (Lorant et al. 2003), preg-
nancy and birth complications (Nosarti et al. 2012),
developmental delay and cognitive impairment
(van Os et al. 1997), autistic traits (Lundstrom et al.
2011), emotional problems and interpersonal difﬁ-
culties during childhood (Cannon et al. 2002a), stressful
or traumatic events and victimization (Thapar et al.
2012) and cannabis use (Moore et al. 2007) are also
associated with increased risk of depression.
In fact, co-morbidity with depression is one of the
most consistent ﬁndings regarding PEs in general
population samples (Dhossche et al. 2002; Scott et al.
2009; Armando et al. 2010; van Rossum et al. 2011;
Varghese et al. 2011; Kelleher et al. 2012a). One in-
terpretation of this is that PEs might be a manifestation
of depression rather than an indication of abnormal
pathology underlying schizophrenia-related disorders.
Understanding how best to conceptualize PEs is im-
portant because this has implications for classiﬁcation
of PEs and for predicting their utility in aiding
our understanding of mechanisms underlying the
aetiology of schizophrenia.
Studies examining latent constructs of psycho-
pathology show that depression and psychosis exist
as separate, but strongly correlated, dimensions in
the general population (Stefanis et al. 2002;
Krabbendam et al. 2004). Given the degree of
co-morbidity, it is therefore not unexpected that most
risk factors for PEs are also associated with risk of de-
pression, as described earlier. Although some studies
have examined risk factors for both depression and
PEs within the same study (Krabbendam et al. 2004;
Breetvelt et al. 2010), as far as we are aware no study
has explicitly tested whether risk factors are shared
between PEs and depression or are psychopathology
speciﬁc while jointly modelling both outcomes to ac-
count for their co-morbidity. Examining to what extent
risk factors for schizophrenia show similar, or differ-
ent, patterns of association with PEs compared to de-
pression can help to shed light on how useful studies
of PEs might be in helping us understand the aetiology
of schizophrenia.
In this study we compared the extent to which risk
factors for schizophrenia across sociodemographic,
familial, neurodevelopmental, stress and adversity,
emotional–behavioural and substance use domains
show different associations with PEs compared to
with depression. We used statistical methods that ac-
count for the correlation between PEs and depression
to avoid the problem of similar associations for PEs




The sample comprised participants from the Avon
Longitudinal Study of Parents and Children (ALSPAC;
www.alspac.bris.ac.uk), an ongoing population-based
study investigating a wide range of inﬂuences on
health and development of children (Boyd et al. 2012).
Ethical approval for the study was obtained from the
ALSPAC Law and Ethics Committee and the Local
Research Ethics Committees. From the initial core sam-
ple of 14541 pregnancies, 13988 children were alive at
12 months. Among these, 7030 children had at least
one measure of interest (depression or PE measures at
either childhood or early adulthood) andwere included
in the analysis.
Measures
Depression outcome at 18 years
The depression outcome measure at 18 years used in
this study was based on the computerized revised
Clinical Interview Schedule (CIS-R; Lewis et al. 1992;
Lewis, 1994), a fully structured interview designed for
community samples. The computerized version shows
very close agreementwith the interviewer-administered
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version (Patton et al. 1999; Bell et al. 2005). The assess-
ment asks questions about the week prior to interview
and the onset and duration of each episode. The de-
pression symptom score reﬂects the severity of de-
pression symptoms and was calculated as the sum of
the scores for the following CIS-R items: depression,
depressive thoughts, fatigue, concentration and sleep
(score range: 0–21). As depression can be considered
as a continuum, we used a cut-off of 10 to indicate the
presence of depression. Selection of this cut-off resulted
in a prevalence of cases that was the same as the pre-
valence of PEs, thus aiding comparison of probit scores
and odds ratios (ORs) for these two outcomes.
PEs at 18 years
PEs at 18 years were assessed using the Psychosis-
Like Symptom interview (PLIKSi; Horwood et al.
2008; Zammit et al. 2013b). The PLIKSi is a semi-
structured instrument that draws on the principles
of standardized clinical examination developed for
the Schedule for Clinical Assessment in Psychiatry
(SCAN) and covers hallucinations (visual and audi-
tory), delusions (spied on, persecution, thoughts
read, reference, control, grandiosity) and experiences
of thought interference (broadcasting, insertion and
withdrawal). Any unspeciﬁed delusions elicited were
also rated. Cross-questioning was used to establish
the presence of symptoms, and coding followed
glossary deﬁnitions and rating rules for the SCAN.
Interviewers rated experiences as not present, sus-
pected or deﬁnitely psychotic that had occurred since
age 12 years. Unclear responses after probing were
always ‘rated down’, and symptoms only rated as
deﬁnite when a clear example was provided. PEs
were coded as present in this study if one or more of
the experiences was either ‘suspected or deﬁnitely
present’ and if they could not be directly attributed
to falling asleep/waking or to fever.
Exposures
Based on evidence from previous literature that these
were associated with schizophrenia, we examined
19 risk factors across the following six domains (see
Table 1 and Supplementary online Appendix 1 for
more detail):
(1) Sociodemographic: gender, ethnicity, maternal
education, maternal marital status, maternal home
ownership, urbanicity.
(2) Familial: family history of depression and family
history of schizophrenia.
(3) Neurodevelopmental: hypoxia at birth, gross
motor development (and change) assessed at 6
and 18 months, cognitive function at 8 years,
and autistic spectrum traits characterized between
6 months and 9 years.
(4) Stress–adversity: life events at 9 years and victimi-
zation at 8 years.
(5) Emotional–behavioural: Strength and Difﬁcult-
ies Questionnaire (SDQ) domains for conduct,
hyperactivity–inattention and peer relationship
problems; the Development and Well Being
Assessment (DAWBA) for anxiety at age 10; the
Short Mood and Feelings Questionnaire (SMFQ)
for depressive symptoms at 12 years; the PLIKSi
for PEs at 12 years.
(6) Substance use: cannabis use up to the age of 16
years.
Statistical analysis
Bivariate probit regression models were used to
jointly model the binary indicators of depression and
PE at 18 years and to test for equality of regression
parameters expressing the effect of exposures on each
outcome using likelihood ratio tests. For this purpose
we compared a model that allowed effect estimates
to differ for our outcomes with a model where the
exposure effect was constrained to be the same for
both outcomes. We converted probit estimates into
ORs to enable presentation of results in a format that
would be more easily interpretable. This was achieved
by obtaining approximations of the logit parameters
by multiplying the probit parameters by a factor of
1.6 (see Amemiya 1981, eq. 2.7; Ntzoufras et al. 2003).
As a sensitivity analysis, we also examined the effect
of exposures (omitting cannabis use and previous
measures of PEs and depression) on a multivariate
outcome that used data on these outcomes across
both ages 12 and 18.
There were signiﬁcant amounts of missing data on
both outcomes. Missing depression or PE outcome
data at 18 years was strongly associated with gender,
socio-economic position and early loss of follow-up.
To deal with missing data, we used multiple impu-
tation (MI; Little & Rubin, 2002) by fully conditional
speciﬁcation using ﬂexible additive imputation models
as implemented in the aregImpute function in the R
statistical package (Harell, 2001; van Buuren et al.
2006). In addition to those included in the analyses,
the imputation model also included variables that
were associated with missingness or were predictive
of depression or PE at 18 years. Approximately 60
auxiliary variables were included in the imputation
model to make the basic assumption underlying MI re-
alistic. These included a wide range of markers of
sociodemographic characteristics during early child-
hood and historical assessments of most exposures
examined (e.g. SDQ scores were assessed repeatedly
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at ages 47 and 81 months, and 8, 9, 10, 11 and 13 years).
Further information is available from the authors.
Parameter estimates were averaged over 100 imputed
datasets using Rubin rules. Wald-type tests were
used following imputation to assess equality or com-
monality of exposure effects.
Results
Descriptive
Of the 7030 individuals in the analysis sample, 4140
had data on PEs at age 18 years. Of these, 370
[9.0%, 95% conﬁdence interval (CI) 8.2–9.9] had at
least one PE present (see Zammit et al. 2013b for further
details). Of 4435 individuals who had data on de-
pression at age 18 years, 410 (9.2%, 95% CI 8.4–10.1)
had a depression score of >10 (cut-off selected to en-
sure similar prevalence of both outcomes). Among
those with PEs at age 18 years, 28% also had de-
pression; and among those with depression, 28% also
had PEs.
The correlation between depression and PE was
0.20 (95% CI 0.09–0.31) at age 12 and 0.22 (95% CI
0.09–0.36) at age 18, and this co-occurrence was
Table 1. Description of exposures under study
Measure Scale Analysis units Sample n n (%) exposed
Sociodemographic
Ethinicity Binary Non-white 6641 277 (4.2)
Urbanicity Binary Rural 6958 449 (6.5)
Sex Binary Female 7030 3626 (51.6)
Marital status of mother Binary Not married 6866 1292 (18.8)
Low maternal education Binary CSEs 6504 662 (9.42)
Home ownership Binary Renting 6800 1164 (17.12)
Familial
Family history of depression Binary Present 6749 1922 (28.5)
Family history of schizophrenia Binary Present 5773 166 (2.88)
Neurodevelopmental
Hypoxia Binary Present 6449 558 (8.7)
Gross motor score at 6 months z scorea S.D. scale 6067
Gross motor score at 18 months z scorea S.D. scale 6297
IQ at 8 years WISC (45–151) NED (1 s.D.=15)b 5811
Autistic spectrum disorder Binary < –1 6957 1104 (15.7)
Stress and adversity
Life events at 7 years 0, 1,52 0 5882 4210 (71.6)
1 1376 (23.4)
52 events 296 (5.0)
Victimization at 8 years Binary Present 5517 2164 (39.2)
Emotional–behavioural
Conduct score at 12 years 0–10 1 s.D.=2a 5662
Hyperactivity score at 12 years 0–10 1 s.D.=2a 5651
Peer problems score at 12 years 0–10 1 s.D.=2a 5663
Depression at 12 years 0–26 >11 score 6344 579 (9.13)
Anxiety disorder at 10 years Binary Present 5774 110 (1.91)
PEs at 12 years Binary Present 6448 745 (11.6)
Substance use
Cannabis use at 16 years Lifetime count Never 4102 2920 (71.2)
<20 times 854 (20.8)
20–60 159 (3.9)
>60 169 (4.12)
CSE, Certiﬁcate of Secondary Education; WISC, Wechsler Intelligence Scale for Children; NED, normal equivalent deviates;
PE, psychotic experience.
a Analysis scale is expressed in standard deviation (S.D.) units where the scale is transformed to have a mean 0 and S.D.=1.
b NED – standardized scale. Raw scores are transformed to z scores (standard normal scores) using the inverse
normal function.
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sustained over time from late childhood to early
adulthood (r=0.72, 95% CI 0.61–0.82).
Common and speciﬁc risk factors
The results for the association between each exposure
and both depression and PEs at age 18 are summarized
in Table 2. Most of the exposures examined within
the sociodemographic, stress and adversity, emotion-
al–behavioural and substance use risk domains were
associated, to a similar degree, with an increased risk
of both outcomes. This was true for low maternal
education, socio-economic disadvantage and single
parenthood at birth, stressful life events, peer victimi-
zation, anxiety disorder, hyperactivity, conduct prob-
lems, peer problems during childhood, and cannabis
use during adolescence.
Most measures of neurodevelopment, including
asphyxia at birth, early motor developmental delay,
lower IQ and autistic traits, were associated with an
increased risk of PEs but not depression. The likeli-
hood ratio tests for these exposures provide support
for the notion that modelling exposure effects as psy-
chopathology speciﬁc provides a better ﬁt to the data
than modelling a common effect across depression
and PEs. There was also strong evidence that PEs
Table 2. Exposure effects (OR and 95% CI) on depression and psychotic experiences (PEs) at 18 yearsa, and examination of whether
psychopathology-speciﬁc effects differ from a common effect
n
Depression PEs Common effect
OR 95% CI OR 95% CI OR 95% CI p valueb
Sociodemographic
Ethnicity (non-White) 3916 1.42 0.95–2.12 1.44 0.97–2.16 1.43 1.05–1.96 0.942
Urbanicity (rural) 4060 0.90 0.64–1.28 0.73 0.50–1.05 0.81 0.62–1.07 0.347
Sex (female) 4100 1.99 1.64–2.38 1.34 1.12–1.60 1.61 1.41–1.86 <0.001
Maternal status (unmarried) 4035 1.58 1.28–1.95 1.74 1.41–2.14 1.66 1.41–1.95 0.467
Maternal education (low) 3847 1.27 0.94–1.71 1.57 1.18–2.09 1.42 1.13–1.78 0.253
Home ownership (rented) 3988 1.60 1.28–1.99 1.67 1.34–2.08 1.63 1.37–1.94 0.745
Familial
Family history of depression 3970 1.45 1.21–1.75 1.10 0.91–1.34 1.27 1.10–1.47 0.023
Family history of schizophrenia 3571 1.57 0.98–2.53 1.33 0.81–2.18 1.45 0.99–2.12 0.584
Neurodevelopmental
Asphyxia 3766 0.79 0.56–1.11 1.30 0.96–1.75 1.03 0.81–1.32 0.015
Gross motor levels 3402 1.04 0.98–1.11 1.08 1.02–1.15 1.06 1.01–1.11 0.323
Gross motor differentials 3402 0.98 0.90–1.06 1.12 1.03–1.22 1.05 0.98–1.11 0.011
IQ 3498 1.00 0.91–1.10 0.88 0.79–0.97 0.94 0.87–1.01 0.037
Autistic spectrum disorder 4100 0.89 0.70–1.14 1.29 1.03–1.61 1.08 0.90–1.03 0.016
Stress and adversity
Life events 3525 1.14 0.99–1.32 1.13 0.98–1.32 1.14 1.01–1.27 0.952
Victimization 3339 1.42 1.17–1.72 1.50 1.23–1.83 1.46 1.25–1.70 0.659
Emotional–behavioural
Conduct 3389 1.24 1.13–1.37 1.27 1.15–1.41 1.26 1.16–1.36 0.704
Hyperactivity 3388 1.11 1.01–1.23 1.21 1.09–1.03 1.16 1.07–1.25 0.209
Peer problems 3390 1.19 1.08–1.31 1.20 1.09–1.33 1.20 1.11–1.29 0.874
Anxiety 3452 1.36 0.71–2.62 1.82 0.98–3.36 1.58 0.96–2.60 0.474
Depression (at 12 years) 3538 3.41 2.63–4.42 2.71 2.07–3.54 3.05 2.48–3.75 0.173
PEs (at 12 years) 3585 2.36 1.84–3.02 4.06 3.20–5.15 3.12 2.59–3.76 <0.001
Substance use
Cannabis use 2959 1.23 1.11–1.36 1.21 1.09–1.34 1.22 1.13–1.32 0.765
OR, Odds ratio; CI, conﬁdence interval.
a Complete case data, bivariate model.
b p values associated with signiﬁcance tests comparing a model assuming psychopathology-speciﬁc effect for each exposure
versus a model where the exposure effect is common/shared (i.e. constrained to be the same across psychopathologies). Small
p values indicate evidence of differences in ﬁt between the two models, whereby the shared-effect model does not provide
adequate ﬁt for the data and a psychopathology-speciﬁc model provides a better ﬁt.
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at age 12 were more strongly associated with PEs
at age 18 than with depression at this age.
By contrast, depression at age 12 led to an approxi-
mately threefold increase in risk of both depression
and PEs at age 18, whereas family history of de-
pression and female sex in particular were more
strongly associated with depression than PEs at age 18.
MI
Data for depression and PEs were both missing at
age 12 years in 8% (n=555) of the 7030 individuals
in the analysis sample, and in 37% (n=2595) at age
18 years. Approximately 50% (n=3524) had data on
both depression and PE outcomes at age 12 and age
18 years. Approximately 36% (n=2519) of those with
data on both depression and PE at age 12 did not
have any outcome data at 18 years, whereas only 7%
(n=501) of those with both depression and PE data
at age 18 did not have any data on either measure
at age 12. Thus the main pattern for missingness
was loss of follow-up. Pooled estimates from MI
were similar to those using the complete-case data,
and conclusions were essentially unchanged (see
online Supplementary Table S1). The results were
also substantively the same when examining a multi-
variate outcome using data on PEs and depression
across both ages 12 and 18 (Supplementary Table S2).
Discussion
In this study we found evidence that most of the estab-
lished risk factors for schizophrenia that we examined
were associated with both PEs and depression during
late adolescence within a general population sample,
even after allowing for the co-morbidity between
these two outcomes. Most of the exposures examined
within the sociodemographic, stress and adversity,
emotional–behavioural and substance use risk do-
mains were associated, to a similar degree, with an
increased risk of both outcomes. However, whereas
female sex and, to a lesser extent, family history of
depression showed some discrimination as potential
risk factors for depression and PEs, occurring more
commonly in the former, markers of abnormal neuro-
development discriminated between these phenotypes,
with stronger associations observed for PEs.
Previous studies
Studies that have examined risk factors for both PEs
and depression have not been able to make direct com-
parisons of effects across these outcomes. For example,
one cross-sectional study examined associations be-
tween sociodemographic characteristics and outcomes
of psychotic symptoms and of depression while
adjusting for (or conditioning on) the other outcome
(Breetvelt et al. 2010). Although there was statistical
evidence that ethnicity and markers of sociodemo-
graphic adversity were associated with both outcomes,
and that female sex was associated with depression but
not PEs, the models used do not permit formal testing
of whether risk factors are shared, and to a similar
extent, across both outcomes or are disorder speciﬁc.
Similarly, another study (Krabbendam et al. 2004)
that examined associations between risk factors and
latent constructs of depression and psychosis in the
general population did not test whether associations
were different across these outcomes, or model these
outcomes jointly to allow for the correlation between
them. Given the high levels of co-morbidity between
depression and PEs in general population samples
(Kelleher et al. 2012a), statistical approaches that can
test for differences between risk factor associations on
these outcomes while allowing for their strong cor-
relation are important.
Consistent with our ﬁndings, there is strong evi-
dence that risk of schizophrenia is increased in indi-
viduals with neurodevelopmental abnormalities. Lon-
gitudinal studies have demonstrated that lower
IQ during childhood and adolescence is associated
with an increased incidence of psychotic disorders
(Khandaker et al. 2011; Dickson et al. 2012), with simi-
lar ﬁndings observed for markers of motor and lan-
guage development during early childhood (Welham
et al. 2009a; Dickson et al. 2012). A wide variety of preg-
nancy and birth complications, including hypoxia-
related exposures, have been associated with risk for
schizophrenia (Cannon et al. 2002b; Welham et al.
2009a), whereas genetic studies have demonstrated
substantial overlap between the genetic aetiology for
schizophrenia with that for autism and other neuro-
developmental disorders (Williams et al. 2010; Doherty
et al. 2012). Although there is also some evidence that
markers of impaired neurodevelopment (van Os et al.
1997; Zammit et al. 2004; Gale et al. 2008, 2009), autistic
traits (Lundstrom et al. 2011) and birth complications
(Nosarti et al. 2012) are associated with risk of de-
pression, these results have been weaker and less con-
sistent than those for schizophrenia (see, for example,
Cannon et al. 2002a), but again no studies have directly
compared associations with schizophrenia and de-
pression within bivariate models that allow for
co-morbidity of these disorders.
Interpretation of ﬁndings
Our ﬁnding, that markers of neurodevelopmental im-
pairment are more strongly associated with PEs than
with depression within such a model, supports the
belief that these experiences are aetiologically related
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to pathological mechanisms underlying schizophrenia,
and that their study might help us to understand
more about neurodevelopmental mechanisms in the
aetiology of this disorder. However, most of the expo-
sures examined were associated with depression and
PEs to the same extent. The argument that PEs are
valid markers for studying the aetiology of schizo-
phrenia, made simply on the basis that they share
risk factors in common with each other, is therefore
not well supported. Furthermore, although neurodeve-
lopmental abnormalities and sex show some discrimi-
nation between PEs and depression, it is feasible that
these characteristics do not discriminate PEs from
other psychopathologies, such as attention deﬁcit
hyperactivity disorder, that were not examined here.
Evidence supports the presence of an extended pheno-
type for psychosis existing across several dimensions,
including an affective domain (David, 2010; Kaymaz
& van Os, 2010). Further examination of the ex-
tent to which speciﬁc characteristics distinguish PEs
from other psychopathologies could lead to a greater
understanding of the aetiology of psychosis.
Strengths and limitations
One of the strengths of our study is that we were able
to examine and compare the effects of a wide range
of risk factors measured longitudinally with respect
to jointly modelled outcomes of depression and PEs.
Although other studies of PEs in general population
samples have described associations with IQ (Cannon
et al. 2002a; Horwood et al. 2008), developmental
delay (Cannon et al. 2002a), autistic traits (Bevan
Jones et al. 2012) and birth complications (Zammit
et al. 2009), none of these have examined whether
associations with PEs are different from those for
depression within multivariate models that take into
account the co-morbidity or correlation of these
outcomes.
One of the main limitations of our study was the
substantial attrition in the cohort over time. However,
the results were very similar in the imputation model
that included measures of the family’s socio-economic
status, lifestyle and mental health, and several mea-
sures of the child’s psychosocial development includ-
ing data from earlier waves of depressive symptoms,
PEs and other emotional and behavioural problems.
Thus the assumption of missing at random conditional
on these is not unrealistic.
Another limitation is that we were not able to
examine all risk factors for schizophrenia, thus re-
stricting the inferences we can make from this study.
Some of the exposures examined such as anxiety
disorders and family history of schizophrenia were
uncommon, and the power to detect differences across
psychopathologies may have been limited. Further-
more, we are not able to determine whether the associ-
ations reported here are causal as we have not explored
the extent to which these associations are confounded
by other variables. However, the aim of this study
was not to examine causal relationships, but to
explore whether characteristics relating to sociodemo-
graphic, developmental and childhood background
differed between individuals with PEs and those
with depression while allowing for their co-morbidity.
Implications
Longitudinal studies have demonstrated that the posi-
tive predictive value of PEs predicting even a broad
phenotype of psychotic disorders is low (Poulton
et al. 2000; Dhossche et al. 2002; Dominguez et al.
2011; Werbeloff et al. 2012; Zammit et al. 2013b), and
this is likely to be even lower for a rarer outcome
such as schizophrenia, whereas there is no evidence
that PEs in population-based samples of adolescents
share a genetic architecture comparable to schizo-
phrenia (Zammit et al. 2013a). In keeping with these
ﬁndings, most of the characteristics we examined, cho-
sen for their consistent associations with schizophrenia
in the literature, were associated equally strongly with
depression as they were with PEs. Although PEs in the
general population may have some clinical utility,
given their association with depression (van Rossum
et al. 2011), suicidality (Kelleher et al. 2012b) and
impaired functioning (Rossler et al. 2007), in the main
they seem to be a weak index of genetic and environ-
mental risk for schizophrenia.
However, our ﬁnding that markers of neurode-
velopmental impairment are more strongly associated
with PEs than with depression lends some support
to the belief that these phenotypes are not just alterna-
tive expressions of a common underlying mechanism,
and that PEs may share some aetiological mechanisms
with schizophrenia. Given their frequency and
relative ease of tracking in birth cohort studies, PEs
might therefore be a useful phenotype to examine
mechanisms by which exposures during early brain
development could impact upon risk for schizo-
phrenia. Identiﬁcation of markers that differentiate
PEs from other psychopathology may enable clinicians
and researchers to identify individuals with substan-
tially higher risk of transition from PEs to clinical psy-
chotic disorder, and where closer monitoring and
earlier intervention might be warranted. More detailed
measures of psychopathology over time and analytical
methods appropriate for maximizing use of such data
are needed to disentangle aetiological pathways to
psychosis from those impacting upon co-morbid
psychopathology.
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